tirzepatide news september 27 2025 📣 BIG IN OBESITY MEDICINE! 🇨🇦 Health Canada has officially approved Zepbound™ KwikPen® (tirzepatide injection) for chronic weight management! Zepbound™ is a once-weekly injectable medication that works by activating two key News - FlyteHealth

In individuals with Alzheimers disease, NAD levels are often reduced, which may be associated with neuroinflammation, cellular injury, and increased proinflammatory cytokines

The global semaglutide API market was valued at approximately $4.8 billion in 2025 and is expected to grow at a CAGR of 16.2% from 2026 to 2034, reaching $18.6 billion by the end of the forecast period

The following represents key Coding Clinic positions relevant to diabetes mellitus as of the most recent published guidance (4Q 2023 through 2025): Long-Term Insulin Use with Type 2 Diabetes Coding Clinic has consistently affirmed that when a Type 2 diabetic patient uses long-term insulin, coders must assign Z79.4 (long-term current use of insulin) as an additional code

BPC-157 : 250-500 1-2 [24]

But from early 2026 in India, Canada, China, Brazil and Turkey, and from 2031 in the UK, Novo Nordisks patent will expire, allowing other companies to produce their own generic versions, according to Medicines UK, which represents manufacturers

Cagrilintide doesnt touch GLP-1 at allit works through amylin and calcitonin receptors, which is a fundamentally different hormonal route